Your browser doesn't support javascript.
loading
Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial.
Shi, M; Gu, A; Tu, H; Huang, C; Wang, H; Yu, Z; Wang, X; Cao, L; Shu, Y; Wang, H; Yang, R; Li, X; Chang, J; Hu, Y; Shen, P; Hu, Y; Guo, Z; Tao, M; Zhang, Y; Liu, X; Sun, Q; Zhang, X; Jiang, Z; Zhao, J; Chen, F; Yu, H; Zhang, W; Sun, J; Li, D; Zhou, J; Han, B; Wu, Y L.
Afiliación
  • Shi M; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
  • Gu A; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Tu H; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Huang C; Department of Thoracic Oncology, Fujian Cancer Hospital, The Affiliated Cancer Hospital of Fujian Medical University, Fuzhou, China.
  • Wang H; Department of Medical Oncology, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Yu Z; Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Wang X; Department of Chemotherapy, Qilu Hospital of Shandong University, Jinan, China.
  • Cao L; Department of Pneumology, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, Hefei, China.
  • Shu Y; Department of Oncology, Jiangsu Province Hospital, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  • Wang H; Department of Medical Oncology, Tianjin Union Medical Centre, Tianjin, China.
  • Yang R; Department of Tumor Chemotherapy, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Center, Kunming, China.
  • Li X; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Chang J; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Hu Y; Department of Medical Oncology, Hubei Cancer Hospital, Wuhan, China.
  • Shen P; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
  • Hu Y; Department of Medical Oncology, Chinese PLA General Hospital, Beijing, China.
  • Guo Z; Department of Pneumology, Shanghai East Hospital, The Affiliated East Hospital of Tongji University, Shanghai, China.
  • Tao M; Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Zhang Y; Department of Thoracic Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
  • Liu X; Department of Medical Oncology, Shantou Central Hospital, Affiliated Shantou Hospital of Sun Yat-Sen University, Shantou, China.
  • Sun Q; Department of Medical Oncology, Henan Provincial Chest Hospital, Zhengzhou, China.
  • Zhang X; Department of Pneumology, The Affiliated Zhongshan Hospital of Fudan University, Shanghai, China.
  • Jiang Z; Department of Medical Oncology, Puyang Oilfield General Hospital, Puyang, China.
  • Zhao J; Department of Medical Oncology, The Affiliated Hospital of Qinghai University, Xining, China.
  • Chen F; School of Public Health, Nanjing Medical University, Nanjing, China.
  • Yu H; School of Public Health, Nanjing Medical University, Nanjing, China.
  • Zhang W; Shanghai Yizhong Biotechnical Co., Ltd., Shanghai, China.
  • Sun J; Shanghai Yizhong Biotechnical Co., Ltd., Shanghai, China.
  • Li D; Shanghai Yizhong Biotechnical Co., Ltd., Shanghai, China.
  • Zhou J; Shanghai Yizhong Biotechnical Co., Ltd., Shanghai, China.
  • Han B; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China. Electronic address: hanxkyy@aliyun.com.
  • Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China. Electronic address: syylwu@live.cn.
Ann Oncol ; 32(1): 85-96, 2021 01.
Article en En | MEDLINE | ID: mdl-33130217
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Nanopartículas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Nanopartículas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido